Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/II study of XNW5004 with CHOP/CHOEP in previously untreated peripheral T-cell lymphoma
CTR20252102Phase 2Active
- Sponsor
- Sinovent
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of igermetostat in peripheral T-cell lymphoma (PTCL), sponsored by Sinovent. Started Aug 2025; status: active.
02
Drugs
igermetostat
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on CTR20252102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252102.